Vanibiss Boric Acid Vaginal Suppositories
Natural health product licensed in Canada
- Other names
- Boric Acid Vaginal Suppositories, Seroflora Boric Acid Vaginal Suppositories
- Licence holder
- Vanibiss Inc.
- NPN or DIN-HM
- 80148362
- Status
- Active licence
- Licence date
- 7 April 2026
- Revision date
- 29 September 2026
- Form
- Suppositoire
- Route of administration
- Vaginale
- Application type
- Générale (non traditionelle)
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Gélatine, Stéarate de magnésium, Silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes | minimum: 18 years | 1 suppositoire | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps relieve recurrent vaginal infections such as candidiasis. Helps reduce the overgrowth of recurrent or resistant vaginal yeast.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80148362
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.